Enovix 10-Q: Q3 Revenue $11.0M, $41.9M Net Loss, Smartphone Program Shelved
ENVX is trading near its 52-week low of $1.785 (8.9% above the low) on elevated volume (2.6× avg).
Summary
Enovix's Q3 10-Q confirms $11.0M revenue and a $41.9M net loss, and discloses it is dropping smartphone field testing while its smart eyewear order slips into 2027. It also bought back $128.0M of 2030 notes at a 36% discount to par.
Key Events · Earnings and Guidance · ENVX
-
Q3 Revenue $11.0M, Net Loss $41.9M
Revenue rose 38% year over year to $11.039M with gross profit of $3.328M; net loss attributable to Enovix was $41.946M, or $0.19 per basic share.
-
Smartphone Program Effectively Shelved
AI-1 no longer meets current customer energy density requirements, so Enovix will not proceed with system-level field testing and has cut AI-1 smartphone development spending, shifting focus to smaller smart eyewear cells.
-
Smart Eyewear Order Slips to 2027
Only about 8,600 AI-1 batteries shipped in Q3 after a manufacturing process excursion; the 50,000-pack order is now expected to complete in the first half of 2027 instead of Q4 2026.
-
$128.0M of 2030 Notes Retired at 36% Discount
October and November repurchases of $128.0M principal cost about $81.4M in cash, leaving $232.0M of 2030 convertible notes outstanding; an additional $15.5M of common stock was repurchased in October.
Analysis · ENVX · Manufacturing
The headline numbers were already out on November 12, but the full 10-Q carries the details that change the story. Enovix is stepping back from smartphone cells entirely — it decided not to proceed with system-level field testing of AI-1 because the technology no longer meets the customer's energy density requirements — and its 50,000-pack smart eyewear order now slips to the first half of 2027 from Q4 2026 after a manufacturing process excursion. Against that, the drone/defense pipeline grew to about $216M and the company retired $128.0M of its 2030 convertible notes for roughly $81.4M in cash, a 36% discount to par that cuts debt cheaply. With $512.2M of cash and investments and $391.3M of working capital, funding is not the near-term issue; execution on the narrowed product roadmap is.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENVX was trading at $1.94 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $396.1M. The 52-week trading range was $1.79 to $9.19. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.